{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:01:04Z","timestamp":1774987264137,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Ministry of Health, Welfare and Family Affairs | Korea National Institute of Health","doi-asserted-by":"publisher","award":["2024-NI-003-00 and 2024-NI-003-01"],"award-info":[{"award-number":["2024-NI-003-00 and 2024-NI-003-01"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-026-00416-y","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:16:28Z","timestamp":1774689388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum 25-hydroxyvitamin D levels and risk of type 2 diabetes according to glycemic status: a prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-8004","authenticated-orcid":false,"given":"Sihan","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kyoung","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Mi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong-Yeon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6698-7368","authenticated-orcid":false,"given":"Hyun-Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"416_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334.","journal-title":"Lancet"},{"key":"416_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"416_CR3","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389:2239\u201351.","journal-title":"Lancet"},{"key":"416_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/dom.12270","volume":"16","author":"C Merlotti","year":"2014","unstructured":"Merlotti C, Morabito A, Pontiroli AE. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diab Obes Metab. 2014;16:719\u201327.","journal-title":"Diab Obes Metab"},{"key":"416_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41574-020-0381-5","volume":"16","author":"F Magkos","year":"2020","unstructured":"Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16:545\u201355.","journal-title":"Nat Rev Endocrinol"},{"key":"416_CR6","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1172\/JCI29449","volume":"116","author":"MF Holick","year":"2006","unstructured":"Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062\u201372.","journal-title":"J Clin Invest"},{"key":"416_CR7","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/nu15081997","volume":"15","author":"J Wu","year":"2023","unstructured":"Wu J, Atkins A, Downes M, Wei Z. Vitamin D in diabetes: uncovering the sunshine hormone\u2019s role in glucose metabolism and beyond. Nutrients. 2023;15:1997.","journal-title":"Nutrients"},{"key":"416_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00125-005-1802-7","volume":"48","author":"C Mathieu","year":"2005","unstructured":"Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia. 2005;48:1247\u201357.","journal-title":"Diabetologia"},{"key":"416_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mce.2011.08.016","volume":"347","author":"H Wolden-Kirk","year":"2011","unstructured":"Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C. Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol. 2011;347:106\u201320.","journal-title":"Mol Cell Endocrinol"},{"key":"416_CR10","doi-asserted-by":"publisher","first-page":"8178","DOI":"10.1080\/10408398.2021.1926220","volume":"62","author":"S Mohammadi","year":"2022","unstructured":"Mohammadi S, Hajhashemy Z, Saneei P. Serum vitamin D levels in relation to type-2 diabetes and prediabetes in adults: a systematic review and dose\u2013response meta-analysis of epidemiologic studies. Crit Rev Food Sci Nutr. 2022;62:8178\u201398.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"416_CR11","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1210\/clinem\/dgae290","volume":"109","author":"MB Demay","year":"2024","unstructured":"Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109:1907\u201347.","journal-title":"J Clin Endocrinol Metab"},{"key":"416_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4093\/dmj.2022.0106","volume":"46","author":"JH Bae","year":"2022","unstructured":"Bae JH, Han K-D, Ko S-H, Yang YS, Choi JH, Choi KM, et al. Diabetes fact sheet in Korea 2021. Diab Metab J. 2022;46:417\u201326.","journal-title":"Diab Metab J"},{"key":"416_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3945\/ajcn.112.048496","volume":"97","author":"S Lim","year":"2013","unstructured":"Lim S, Kim MJ, Choi SH, Shin CS, Park KS, Jang HC, et al. Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk Asian subjects. Am J Clin Nutr. 2013;97:524\u201330.","journal-title":"Am J Clin Nutr"},{"key":"416_CR14","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1093\/ije\/dyv316","volume":"46","author":"Y Kim","year":"2017","unstructured":"Kim Y, Han B-G. KoGES Group. Cohort profile: the Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2017;46:e20.","journal-title":"Int J Epidemiol"},{"key":"416_CR15","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine-and cystatin C\u2013based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349.","journal-title":"N Engl J Med"},{"key":"416_CR16","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1056\/NEJM199204303261806","volume":"326","author":"JP Bilezikian","year":"1992","unstructured":"Bilezikian JP. Management of acute hypercalcemia. N Engl J Med. 1992;326:1196\u2013203.","journal-title":"N Engl J Med"},{"key":"416_CR17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3945\/ajcn.112.054502","volume":"97","author":"MC Sachs","year":"2013","unstructured":"Sachs MC, Shoben A, Levin GP, Robinson-Cohen C, Hoofnagle AN, Swords-Jenny N, et al. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2013;97:1243\u201351.","journal-title":"Am J Clin Nutr"},{"key":"416_CR18","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice Committee.","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142022. Diab Care. 2022;45:S17\u2013S38.","journal-title":"Diab Care"},{"key":"416_CR19","unstructured":"World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000."},{"key":"416_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"416_CR21","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1210\/jc.2013-3883","volume":"99","author":"N Veronese","year":"2014","unstructured":"Veronese N, Sergi G, De Rui M, Bolzetta F, Toffanello ED, Zambon S, et al. Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: the PRO.V.A. study. J Clin Endocrinol Metab. 2014;99:2351\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"416_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2016.07.001","volume":"90","author":"N Napoli","year":"2016","unstructured":"Napoli N, Schafer AL, Lui LY, Cauley JA, Strotmeyer ES, Le Blanc ES, et al. Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the osteoporotic fractures in men (MrOS) study. Bone. 2016;90:181\u20134.","journal-title":"Bone"},{"key":"416_CR23","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2337\/dc07-0292","volume":"30","author":"C Mattila","year":"2007","unstructured":"Mattila C, Knekt P, M\u00e4nnist\u00f6 S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diab Care. 2007;30:2569\u201370.","journal-title":"Diab Care"},{"key":"416_CR24","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1464-5491.2010.03092.x","volume":"27","author":"G Grimnes","year":"2010","unstructured":"Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Nj\u00f8lstad I, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Troms\u00f8 Study 1994\u201395 and risk of developing type 2 diabetes mellitus during 11\u2003years of follow-up. Diabet Med. 2010;27:1107\u201315.","journal-title":"Diabet Med"},{"key":"416_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41387-022-00220-4","volume":"12","author":"JJ Joseph","year":"2022","unstructured":"Joseph JJ, Langan S, Lunyera J, Kluwe B, Williams A, Chen H, et al. The association of serum vitamin D with incident diabetes in an African American population. Nutr Diab. 2022;12:43.","journal-title":"Nutr Diab"},{"key":"416_CR26","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00125-012-2544-y","volume":"55","author":"NG Forouhi","year":"2012","unstructured":"Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173\u201382.","journal-title":"Diabetologia"},{"key":"416_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2337\/dc12-1050","volume":"36","author":"A Tsur","year":"2013","unstructured":"Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diab Care. 2013;36:1361\u20137.","journal-title":"Diab Care"},{"key":"416_CR28","doi-asserted-by":"publisher","first-page":"e0193070","DOI":"10.1371\/journal.pone.0193070","volume":"13","author":"SK Park","year":"2018","unstructured":"Park SK, Garland CF, Gorham ED, BuDoff L, Barrett-Connor E. Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. PLoS One. 2018;13:e0193070.","journal-title":"PLoS One"},{"key":"416_CR29","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1210\/clinem\/dgae221","volume":"109","author":"Y Fu","year":"2024","unstructured":"Fu Y, Lu M, Zhang K, Sun Y, Tan X, Wang N, et al. Vitamin D status, vitamin D receptor polymorphisms, and risk of type 2 diabetes: A prospective cohort study. J Clin Endocrinol Metab. 2024;109:2173\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"416_CR30","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00592-024-02368-0","volume":"62","author":"CK Rohold","year":"2025","unstructured":"Rohold CK, J\u00f8rgensen HL, Vojdeman FJ, Madsen CM, Olsen A, Heegaard A-M, et al. Levels of plasma 25-hydroxy vitamin D and risk of developing type 2 diabetes in a large Danish primary health care population. Acta Diabetol. 2025;62:397\u2013404.","journal-title":"Acta Diabetol"},{"key":"416_CR31","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/dme.13113","volume":"33","author":"JB Echouffo-Tcheugui","year":"2016","unstructured":"Echouffo-Tcheugui JB, Narayan KM, Weisman D, Golden SH, Jaar BG. Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis. Diabet Med. 2016;33:1615\u201324.","journal-title":"Diabet Med"},{"key":"416_CR32","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398:786\u2013802.","journal-title":"Lancet"},{"key":"416_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7326\/M22-3018","volume":"176","author":"AG Pittas","year":"2023","unstructured":"Pittas AG, Kawahara T, Jorde R, Dawson-Hughes B, Vickery EM, Angellotti E, et al. Vitamin D and risk for type 2 diabetes in people with prediabetes: A systematic review and meta-analysis of individual participant data from 3 randomized clinical trials. Ann Intern Med. 2023;176:355\u201363.","journal-title":"Ann Intern Med"},{"key":"416_CR34","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1210\/jc.2007-0298","volume":"92","author":"AG Pittas","year":"2007","unstructured":"Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017\u201329.","journal-title":"J Clin Endocrinol Metab"},{"key":"416_CR35","first-page":"E356","volume":"267","author":"JA Johnson","year":"1994","unstructured":"Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol. 1994;267:E356\u201360.","journal-title":"Am J Physiol"},{"key":"416_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2004.03.115","volume":"89-90","author":"R Bland","year":"2004","unstructured":"Bland R, Markovic D, Hills CE, Hughes SV, Chan SLF, Squires PE, et al. Expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89-90:121\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"416_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.6250216","volume":"209","author":"AW Norman","year":"1980","unstructured":"Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science. 1980;209:823\u20135.","journal-title":"Science"},{"key":"416_CR38","first-page":"528","volume":"105","author":"Y Tanaka","year":"1984","unstructured":"Tanaka Y, Seino Y, Ishida M, Yamaoka K, Yabuuchi H, Ishida H, et al. Effect of vitamin D3 on the pancreatic secretion of insulin and somatostatin. Acta Endocrinol (Copenh). 1984;105:528\u201333.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"416_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1210\/endo-119-1-84","volume":"119","author":"C Cade","year":"1986","unstructured":"Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119:84\u201390.","journal-title":"Endocrinology"},{"key":"416_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1507\/endocrj.47.383","volume":"47","author":"B Maestro","year":"2000","unstructured":"Maestro B, Campi\u00f3n J, D\u00e1vila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000;47:383\u201391.","journal-title":"Endocr J"},{"key":"416_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/cbf.951","volume":"20","author":"B Maestro","year":"2002","unstructured":"Maestro B, Molero S, Bajo S, D\u00e1vila N, Calle C. Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D. Cell Biochem Funct. 2002;20:227\u201332.","journal-title":"Cell Biochem Funct"},{"key":"416_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0960-0760(03)00032-3","volume":"84","author":"B Maestro","year":"2003","unstructured":"Maestro B, D\u00e1vila N, Carranza MC, Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84:223\u201330.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"416_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12018-009-9041-y","volume":"7","author":"M Eliades","year":"2009","unstructured":"Eliades M, Pittas AG. Vitamin D and type 2 diabetes. Clin Rev Bone Min Metab. 2009;7:185\u201398.","journal-title":"Clin Rev Bone Min Metab"},{"key":"416_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","volume":"97","author":"E van Etten","year":"2005","unstructured":"van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. J Steroid Biochem Mol Biol. 2005;97:93\u2013101.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"416_CR45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/1055-9965.EPI-09-1121","volume":"19","author":"JN Hofmann","year":"2010","unstructured":"Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP. Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomark Prev. 2010;19:927\u201331.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"416_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3390","volume":"15","author":"S Scarmo","year":"2013","unstructured":"Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, et al. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res. 2013;15:R15.","journal-title":"Breast Cancer Res"},{"key":"416_CR47","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/aje\/kwq005","volume":"171","author":"R Jorde","year":"2010","unstructured":"Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010;171:903\u20138.","journal-title":"Am J Epidemiol"},{"key":"416_CR48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1373\/clinchem.2011.172155","volume":"58","author":"CJ Farrell","year":"2012","unstructured":"Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58:531\u201342.","journal-title":"Clin Chem"},{"key":"416_CR49","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.clinbiochem.2015.08.005","volume":"48","author":"SP Wyness","year":"2015","unstructured":"Wyness SP, Straseski JA. Performance characteristics of six automated 25-hydroxyvitamin D assays: Mind your 3s and 2s. Clin Biochem. 2015;48:1089\u201396.","journal-title":"Clin Biochem"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00416-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00416-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:17:23Z","timestamp":1774984643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-026-00416-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1038\/s41387-026-00416-y","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This study was approved by the Institutional Review Board of the KDCA (Nos. KDCA-2024-02-12-P-01 and 2022-07-07-C-A). The Ansan\u2013Ansung cohort was approved by the Institutional Review Boards of the KoGES group collaborators and KDCA. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"8"}}